| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.95 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Oncological protein-drug complex is being developed in TEVA, Haarlem, as well as the encompassing manufacture process engineering buildup. Due to poor solubility of the studied active pharmaceutical ingredient, organic solvent is used during compounding stage and needs to be sub sequentially removed. Its long removal duration impacts key process parameters such as nano-suspension stability and formation of undesired crystals.
The overall purpose of this study was to determine the feasibility of implementing an air stripping process unit in the existing line of production which would be a breakthrough in the current process by accelerating the solvent removal. The column was tested in pilot plant scale in order to collect and analyze experimental data to determine column’s operational parameters and hydrodynamic properties as well as its efficiency and overall process time reduction by air stripping unit introduction.
Presence of protein and nano-particles was proved to have delaying effect on solvent mass transfer rate due to increased interface resistance and diffusional limitation due to nano-suspension heterogeneous model. The introduction of the column experimentally showed significant improvement in terms of overall evaporation reduction time; from 30 to about 5 hours, depending on the operating parameters and the set-up. The column was additionally designed to fit the model and could reach a theoretical value of 2 hours of stripping for a 500L solution at a maximum of 4 L/min and 30°C to avoid foam and protein denaturation respectively. The air stripping process did not de-stabilize the nano-suspension, showing constant particle size and polydispersity index.
The optimistic collected results validate the advantages of air stripping column implementation in the complex drug manufacture and suggest future work and research with column can be sustained.
Descrição
Palavras-chave
Air stripping column API-protein bound drug complex nano-suspension mass transfer rate hydrodynamics design of experiments
